This qualitative study explored how mandatory child protective services reporting for prenatal exposure to prescribed medications for opioid use disorder affects pregnant and postpartum patients. The researchers analyzed 26 semi-structured interviews conducted as part of a broader study of medication treatment during pregnancy and after delivery, focusing on experiences with Massachusetts reporting policies.
Three themes emerged: participants viewed reporting related to prescribed treatment as unfair and stigmatizing; anticipated or actual child protective services involvement was experienced as stressful and potentially harmful to family wellbeing; and patients felt caught between clinical recommendations and child welfare requirements when making treatment decisions. The authors recommend separating decisions about evidence-based opioid use disorder treatment from automatic reporting triggered solely by prescribed medication exposure.
Original summary for clinical review. Read the published study.
